SGI
SYNH

Summit Global Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Summit Global Investments’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,400
Closed -$385K – 295
2017
Q1 		$385K Hold
8,400
– – 0.13% 190
2016
Q4 		$442K Buy
+8,400
New +$407K 0.16% 141

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Summit Global Investments's SYNH Position: Q2 2017 in Review

Summit Global Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 8,400 shares — an estimated $385K sold.

Summit Global Investments first reported a position in SYNH in Q4 2016 and held it in 2 quarters. The position peaked at $442K in Q4 2016. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

  • Summit Global Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
  • Summit Global Investments sold 8,400 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $385K.
  • Summit Global Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 2 quarters.
  • Summit Global Investments's Syneos Health, Inc. Class A Common Stock position peaked at $442K in Q4 2016.
  • 247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Summit Global Investments's 13F filing for Q2 2017, filed 10 Aug 2017.